NL-OMON34827
Withdrawn
Not Applicable
Wear rate of a Highly Cross-Linked polyethylene stabilized with vitamin E in Total Hip Arthroplasty.;A Randomized Controlled Trial - HipVit
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- 10005944
- Sponsor
- Diakonessenhuis Utrecht
- Enrollment
- 200
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients scheduled for a total hip arthroplasty. Inclusion criterion, patients diagnosed for coxarthrosis, dysplastic coxarthrosis, rheumatoid arthritis , necrosis of the head of the femur or posttraumatic coxarthrosis. Patients between 20 and 75 years old at the time of inclusion.
Exclusion Criteria
- •Exclusion criteria; patients designated for revision surgery, suffer from sepsis, malignant tumours, severe diabetes mellitus, severe cardiovascular diseases (ASA\>II)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
DEFERASIROX GASTROINTESTINAL TOLERABILITY STUDYtransfusional haemosiderosisMedDRA version: 14.1Level: PTClassification code 10019024Term: HaemosiderosisSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2010-023217-61-GBniversity College London64
Active, not recruiting
Phase 1
A study to assess the effect of itraconazole and phenytoin on BIIB113 and the effect of BIIB113 on midazolam in healthy participantsISRCTN48011192Biogen (United Kingdom)70
Completed
Not Applicable
A randomized, open-label, two-period, crossover study to determine the pharmacokinetics of reconstituted lyophilized Erelzi and Enbrel® (US-licensed) following a single subcutaneous injection in healthy male subjects.NL-OMON45782Hexal AG56
Completed
Not Applicable
Comparison between the SpirofyTM Spirometer newly developed by Cipla Ltd. with an existing Spirometer (Vitalograph Alpha Touch Spirometer) in healthy, asthmatic and COPD SubjectsHealth Condition 1: J449- Chronic obstructive pulmonary disease, unspecifiedHealth Condition 2: J459- Other and unspecified asthmaCTRI/2021/09/036492Cipla Limited90
Recruiting
Not Applicable
An exploratory study to evaluate systemic exposure of captopril according to change of urine environmentDiseases of the circulatory systemKCT0009261Seoul National University Hospital12